Environment, dysbiosis, immunity and sex-specific susceptibility: A translational hypothesis for regressive autism pathogenesis

References

• Levy SE, Mandell DS, Schultz RT. Autism. Lancet 2009;374:1627–38.
   PubMed Web of Science ®Google Scholar
• Goldberg WA, Osann K, Filipek PA, Laulhere T, Laulhere T, Jarvis K, et al. Language and other regression: assessment and timing. J Autism Dev Disord 2003;33:607–16.
   PubMed Web of Science ®Google Scholar
• Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res 2009;65:591–8.
   PubMed Web of Science ®Google Scholar
• Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol 2013;36:67–81.
   PubMed Web of Science ®Google Scholar
• Buie T, Fuchs GJ, Furuta GT, Kooros K, Levy J, Lewis JD, et al. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics 2010;125 (Suppl 1):S19–29
   PubMed Web of Science ®Google Scholar
• Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol 2011;11:22.
   PubMed Web of Science ®Google Scholar
• Rubenstein JLR, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003;2:255–67.
   PubMed Web of Science ®Google Scholar
• Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009;136:2003–14.
   PubMed Web of Science ®Google Scholar
• Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013;18:666–673.
   PubMed Web of Science ®Google Scholar
• Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13:701–12.
   PubMed Web of Science ®Google Scholar
• Fuchs S, Sontag G, Stidl R, Ehrlich V, Kundi M, Knasmuller S. Detoxification of patulin and ochratoxin A, two abundant mycotoxins, by lactic acid bacteria. Food Chem Toxicol 2008;46:1398–407.
   PubMed Web of Science ®Google Scholar
• Aureli P, Capurso L, Castellazzi AM, Clerici M, Giovannini M, Morelli L, et al. Probiotics and health: An evidence-based review. Pharmacol Res 2011;63:366–76.
   PubMed Web of Science ®Google Scholar
• Weber TK, Polanco I. Gastrointestinal microbiota and some children diseases: a review. Gastroenterol Res Pract. 2012; 2012:676585.
   PubMed Web of Science ®Google Scholar
• O'Hara A, O'Regan P, Fanning A, O'Mahony C, MacSharry J, Lyons A. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006;118:202–15.
   PubMed Web of Science ®Google Scholar
• Turroni F, Ribbera A, Foroni E, van Sinderen D, Ventura M. Human gut microbiota and Bifidobacteria: from composition to functionality. Antonie van Leeuwenhoek 2008;94:35–50.
   PubMed Web of Science ®Google Scholar
• El-Ansary A, Shaker GH, Rizk MZ. Role of gut–brain axis in the etiology of neurodevelopmental disorders with reference to autism. J Clin Toxicol 2013;S6:1–8.
   Google Scholar
• Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000;54:263–7.
   PubMed Web of Science ®Google Scholar
• Uehara Y, Kikuchi K, Nakamura T, Nakama H, Agematsu K, Kawakami Y, et al. Inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns by Viridans group Streptococci. Clin Infect Dis 2001;32:1399–407.
   PubMed Web of Science ®Google Scholar
• Noverr M, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol 2004;12(12):562–8.
   PubMed Web of Science ®Google Scholar
• Böhmig GA, Krieger PM, Säemann MD, Wenhardt C, Pohanka E, Zlabinger GJ. n-Butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids. Immunology 1997;92(2):234–43.
   PubMed Web of Science ®Google Scholar
• Wagner RD, Pierson C, Warner T, Dohnalek M, Farmer J, Roberts L, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997;65(10):4165–72.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010;16:444–53.
   PubMed Web of Science ®Google Scholar
• Song Y, Liu C, Finegold SM. Real-time PCR quantitation of Clostridia in feces of autistic children. Appl Environ Microbiol 2004;70(11):6459–65.
   PubMed Web of Science ®Google Scholar
• Gondalia SV, Palombo EA, Knowles SR, Cox SB, Meyer D, Austin DW. Molecular characterization of gastrointestinal microbiota of children (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res 2012;5(6):419–27.
   PubMed Web of Science ®Google Scholar
• Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005;54:987–91.
   PubMed Web of Science ®Google Scholar
• Finegold SM. State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe 2011;17:367–8.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Downes J, Summanen PH. Microbiology of regressive autism. Anaerobe 2012;18:260–2.
   PubMed Web of Science ®Google Scholar
• Robinson CJ, Bohannan BJ, Young VB. From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev 2010;74:453–76.
   PubMed Web of Science ®Google Scholar
• Finegold SM. Therapy and epidemiology of autism-clostridial spores as key elements. Med Hypotheses 2008;70:508–11.
   PubMed Web of Science ®Google Scholar
• Kang DW, Park JG, Ilhan ZE, Wallstrom G, LaBaer J, Adams JB, et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS ONE 2013;8:e68322.
   PubMed Web of Science ®Google Scholar
• Lonsdale D, Shamberger RJ, Aduya T. Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuro Endocrinol Lett 2002;23:303–8.
   PubMed Web of Science ®Google Scholar
• Arumugan M, Raes J, Pellettier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of human gut microbiome. Nature 2011;473:174–80.
   PubMed Web of Science ®Google Scholar
• Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222–7.
   PubMed Web of Science ®Google Scholar
• Baquero F, Nombela C. The microbiome as human organ. Clin Microbiol Infect 2012;18(S4):2–4.
   PubMed Web of Science ®Google Scholar
• MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition and neuro inflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res 2011;217:47–54.
   PubMed Web of Science ®Google Scholar
• Fry RE, MacFabe DF. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl Psychiatry 2013;3:e220.
   PubMed Web of Science ®Google Scholar
• Shaw W, Kassen E, Chaves E. Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem 1995;41:1094–104.
   PubMed Web of Science ®Google Scholar
• Shaw W, Kassen E, Chaves E. Assessment of antifungal drug therapy in autism by measurement of suspected microbial metabolites in urine with gas chromatography-mass spectrometry. Clin Pract Alter Med 2000;1:15–26.
   Google Scholar
• Kalużna-Czaplińska J, Błaszczyk S. The level of arabinitol in autistic children after probiotic therapy. Nutrition 2012;28(2):124–6.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002;35 (Suppl 1):S6–S16.
   PubMed Web of Science ®Google Scholar
• Kidd PM. Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev 2002;7:472–99.
   PubMedGoogle Scholar
• Williams BL, Hornig M, Buie T, Bauman ML, Cho Paik M, Wick I, et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS ONE 2011;6:e24585.
   PubMed Web of Science ®Google Scholar
• De Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 2010;51:418–24.
   PubMed Web of Science ®Google Scholar
• Prakash S, Tomaro-Duchesneau C, Saha S, Cantor A. The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells. J Biomed Biotechnol 2011; Article ID 981214.
   PubMedGoogle Scholar
• Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011;108 (Suppl 1):4578–85.
   PubMed Web of Science ®Google Scholar
• Eriksson MA, Westerlund J, Anderlid BM, Gillberg C, Fernell E. First-degree relatives of young children with autism spectrum disorders: some gender aspects. Res Dev Disabil 2012;33:1642–8.
   PubMed Web of Science ®Google Scholar
• Mulle JG, Sharp WG, Cubells JF. The gut microbiome: a new frontier in autism research. Curr Psychiatr Rep 2013;15(2):337.
   PubMed Web of Science ®Google Scholar
• Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Pediatr 2009;98:229–38.
   PubMed Web of Science ®Google Scholar
• Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010;107(26):11971–5.
   PubMed Web of Science ®Google Scholar
• Clemente JC, Ursell LK, Wegener Parfrey L, Knight R. The impact of gut microbiota on human health: an integrative view. Cell 2013;148:1258–70.
   Web of Science ®Google Scholar
• Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364(3):225–64.
   Web of Science ®Google Scholar
• Meldrum SJ, Strunk T, Currie A, Prescott SL, Simmer K, Whitehoue AJO. Autism spectrum disorder in children born preterm-role of exposure to perinatal inflammation. Front Neurosci 2013;7:1–10.
   PubMed Web of Science ®Google Scholar
• Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
   PubMed Web of Science ®Google Scholar
• Newburg DS. Neonatal protection by innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 2009;87:26–34.
   PubMed Web of Science ®Google Scholar
• Perez PF, Dorè J, Leclerc M, Levenez F, Benyacoub J, Serrant P, et al. Bacterial imprinting of neonatal immune system: a lesson from maternal cells? Pediatrics 2007;119:e724–32.
   PubMed Web of Science ®Google Scholar
• Hunt KM, Foster JA, Forney LJ, Schütte UM, Beck DL, Abdo Z, et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS ONE 2011;6(6):e21313.
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 2001;345:1331–5.
   PubMed Web of Science ®Google Scholar
• Lainhart JE, Ozonoff S, Coon H, Krasny L, Dinh E, Nice J, et al. Autism, regression, and the broader autism phenotype. Am J Med Genet 2002;113:231–7.
   PubMed Web of Science ®Google Scholar
• Atladóttir HO, Henriksen TB, Schendel DE, Parner ET. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 2012;103(6):e1447–54.
   Web of Science ®Google Scholar
• Tajima-Pozo K, Zambrano-Enriquez D, De Anta L, Zelmanova J, De Dios Vega JL, Lopez-Ibor J. Otitis and autism spectrum disorders. BMJ Case Rep 2010; 2010: bcr10.2009.2351.
   PubMedGoogle Scholar
• Strömland K, Miller M, Sjögreen L, Johansson M, Joelsson BME, Billstedt E, et al. Oculo-auriculo vertebral spectrum: associated anomalies, functional deficits and possible developmental risk factors. Am J Med Genet 2007;143A:1317–25.
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6(11):e280.
   PubMed Web of Science ®Google Scholar
• Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007;1(1):56–66.
   PubMed Web of Science ®Google Scholar
• Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001;1(2):101–14.
   PubMedGoogle Scholar
• Sommer MO, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009;325(5944):1128–31.
   PubMed Web of Science ®Google Scholar
• Fallon J. Could one of the most prescribed antibiotics amoxicillin/clavunalate ‘augmentin’™ be a risk factor for autism? Med Hypotheses 2005;64:312–5.
   PubMed Web of Science ®Google Scholar
• Schrag S, Zywicki S, Farley M, Reingold Al, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New Engl J Med 2000;342:15–20.
   PubMed Web of Science ®Google Scholar
• Reichelt KL, Knivsberg AM. The possibility and probability of a gut-to-brain connection in autism. Ann Clin Psychiatry 2009;21:205–11.
   PubMed Web of Science ®Google Scholar
• Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000;15:429–35.
   PubMed Web of Science ®Google Scholar
• Golnik AE, Ireland M. Complementary alternative medicine for children with autism: a physician survey. J Autism Dev Disord 2009;39:996–1005.
   PubMed Web of Science ®Google Scholar
• Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P. The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011;161358.
   Google Scholar
• Bolte ER. Autism and Clostridium tetani. Med Hypotheses 1998;51:133–44.
   PubMed Web of Science ®Google Scholar
• Bebawy M, Chetty M. Gender differences in p-glycoprotein expression and function: effects on drug disposition and outcome. Curr Drug Metab 2009;10(4):322–8.
   PubMed Web of Science ®Google Scholar
• Sharp WG, Jaquess DL, Lukens CT. Multi-method assessment of feeding problems among children with autism spectrum disorders. Res Autism Spectr Disord 2013;7:56–65.
   Web of Science ®Google Scholar
• Roshchina VV. Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells. In: Lyte M, (ed.). Microbial endocrinology: Interkingdom signaling in infectious disease and health. Freestone PPE editions. New York: Springer; 2010. p. 17–52.
   Google Scholar
• Norris V, Molina F, Gewirtz AT. Hypothesis: bacteria control host appetites. J Bacteriol 2013;195(3):411–6.
   PubMed Web of Science ®Google Scholar
• Lyte M. Microbial endocrinology and nutrition: a perspective on new mechanisms by which diet can influence gut-to-brain communication. Pharm Nutr 2013;1:35–9.
   Google Scholar
• LeBlanc JJ, Fagiolini M. Autism: a ‘critical period’ disorder? Neural Plast 2011; 2011:921680.
   PubMed Web of Science ®Google Scholar
• Bardin J. Unlocking the brain. Nature 2012;487:24–6.
   PubMed Web of Science ®Google Scholar
• Marco EJ, Hinkley LBN, Hill SS, Nagarajan SS. Sensory processing in autism: a review of neurophysiologic findings. Pediatric Res 2011;69:48R–54R.
   PubMed Web of Science ®Google Scholar
• Simmons DR, Robertson AE, McKay LS, Toal E, McAleer P, Pollick FE. Vision in autism spectrum disorders. Vis Res 2009;49:2705–39.
   PubMed Web of Science ®Google Scholar
• Fagiolini M, Katagiri H, Miyamoto H, Mori H, Grant SG, Mishina M, et al. Separable futures of visual cortical plasticity revealed by N-methyl-D-aspartate receptor 2A signaling. Proc Natl Acad Sci USA 2003;100(5):2854–9.
   PubMed Web of Science ®Google Scholar
• Fagiolini M, Fritschy JM, Löw K, Möhler H, Rudolph U, Hensch TK. Specific GABBA circuits for visual cortical plasticity. Science 2004;303:1681–3.
   PubMed Web of Science ®Google Scholar
• Hensch TK, Fagiolini M, Mataga N, Stryker MP, Baekkeskov S, Kash SF. Local GABBA circuit control of experience-dependent plasticity in developing visual cortex. Science 1998;282:1504–8.
   PubMed Web of Science ®Google Scholar
• Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010;468:263–9.
   PubMed Web of Science ®Google Scholar
• Gonzalez A, Stombaugh J, Lozupone C, Turnbaugh PJ, Gordon JI, Knight R. The mind-body-microbial continuum. Dialogues Clin Neurosci 2011;13:55–62.
   PubMedGoogle Scholar
• Gonzalez-Ferero D, Morcuende S, Alvarez FJ, de la Cruz RR, Pastor AM. Transynaptic effects of tetanus neurotoxin in the oculomotor system. Brain 2005;128:2175–88.
   PubMed Web of Science ®Google Scholar
• Banks WA, Erickson MA. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 2010;37:26–32.
   PubMed Web of Science ®Google Scholar
• Bengmark S. Gut microbiota, immune development and function. Pharmacol Res 2013;69:87–113.
   PubMed Web of Science ®Google Scholar
• Kuwabara H, Yamasue H, Koike S, Inoue H, Kawakubo Y, Kuroda M, et al. Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time of flight mass spectroscopy study. PLoS ONE 2013;8(9):e73814.
   PubMed Web of Science ®Google Scholar
• Louis P. Does the human gut microbiota contribute to the etiology of autism spectrum disorders? Dig Dis Sci 2012;57:1987–9.
   PubMed Web of Science ®Google Scholar
• Shaw W. Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr Neurosci 2010;13:135–43.
   PubMed Web of Science ®Google Scholar
• Ming X, Stein TP, Barnes V, Rhodes N, Guo L. Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome 2012;11:5856–62.
   Google Scholar
• Mavel S, Nadal-Desbarats L, Blasco H, Bonnet-Brilhault F, Barthelemy C, Montigny F, et al. 1H-13C NMR-based urine metabolic profiling in autism spectrum disorders. Talanta 2013;95–102.
   Google Scholar
• Scharf DH, Heinekamp T, Remme N, Hortschansky P, Brakhage AA, Hertweck C. Biosynthesis and function of gliotoxin in Aspergillus fumigatus. Appl Microbiol Biotechnol 2012;93:467–72.
   PubMed Web of Science ®Google Scholar
• Sugui JA, Pardo J, Chang YC, Zarember KA, Nardone G, Galvez EM, et al. Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryot Cell 2007;6:1562–9.
   PubMed Web of Science ®Google Scholar
• Diana M, Peana AT, Sirca D, Lintas A, Melis E, Enrico P. Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system. Ann NY Acad Sci 2008;1139:307–17.
   PubMed Web of Science ®Google Scholar
• Cheng SC, Chai LY, Joosten LA, Vecchiarelli A, Hube V, Van der Meer JW, et al. Candida albicans releases soluble factors that potentiate cytokine production by human cells through a protease-activated receptor 1- and 2-independent pathway. Infect Immun 2010;78:393–9.
   PubMed Web of Science ®Google Scholar
• Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009;207:111–6.
   PubMed Web of Science ®Google Scholar
• Reichelt KL, Knivsberg AM. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutr Neurosci 2003;6:19–28.
   PubMed Web of Science ®Google Scholar
• Hopper DG, Bolton VE, Guilford FT, Straus DC. Mycotoxin detection in human samples from patients exposed to environmental molds. Int J Sci 2009;10:1465–75.
   Google Scholar
• Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 2010;9:2996–3004.
   PubMed Web of Science ®Google Scholar
• Clayton TA. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Lett 2012;586:956–61.
   PubMed Web of Science ®Google Scholar
• Kost NV, Sokolov OY, Kurasova OB, Dmitriev AD, Tarakanova JN, Gabaeva MV, et al. Beta-casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides 2009;30:1854–60.
   PubMed Web of Science ®Google Scholar
• Trezza V, Damsteegt R, Achterberg EJ, Vanderschuren LJ. Nucleus accumbens μ-opioid receptors mediate social reward. J Neurosci 2011;31:6362–70.
   PubMed Web of Science ®Google Scholar
• Reichelt KL, Tveiten D, Knivsberg AM, Bronstad G. Peptide's role in autism with emphasis on exorphins. Microbiol Ecol Health Dis 2012;23:18958.
   PubMedGoogle Scholar
• Leboyer M, Bouvard MP, Launay JM, Recasens C, Plumet MH, Waller-Perotte D, et al. Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone. Encephale 1993;19:95–102.
   PubMedGoogle Scholar
• Cieślińska A, Kostyra E, Kostyra H, Oleński K, Fiedorowicz E, Kaminski S. Milk from cows of different β-casein genotypes as a source of β-casomorphin-7. Int J Food Sci Nutr 2012;63:426–30.
   PubMed Web of Science ®Google Scholar
• EFSA. (European Food Safety Authority) Review of the potential health impact of β-casomorphins and related peptides. EFSA Sci Rep 2009;231:1–107.
   Google Scholar
• Bouhet S, Oswald IP. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet Immunol Immunopathol 2005;108:199–209.
   PubMed Web of Science ®Google Scholar
• Belmadani A, Tramu G, Betbeder AM, Steyn PS, Creppy EE. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain. Arch Toxicol 1998;72:656–62.
   PubMed Web of Science ®Google Scholar
• Puel O, Galtier P, Oswald IP. Biosynthesis and toxicological effects of patulin. Toxins 2010;2:613–31.
   PubMed Web of Science ®Google Scholar
• Sava V, Reunova O, Velasquez A, Harbison R, Sànchez-Ramos J. Acute neurotoxic effects of the fungal metabolite ochratoxin-A. Neurotoxicology 2006;27:82–92.
   PubMed Web of Science ®Google Scholar
• Doi K, Uetsuka K. Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways. Int J Mol Sci 2011;12:5213–37.
   PubMed Web of Science ®Google Scholar
• Bouhet S, Oswald IP. The intestine as a possible target for fumonisin toxicity. Mol Nutr Food Res 2007;51:925–31.
   PubMed Web of Science ®Google Scholar
• Faber S, Zinn GM, Kern JC, Kingston HM. The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 2009;14:171–80.
   PubMed Web of Science ®Google Scholar
• Razafimanjato H, Garmy N, Guo XJ, Varini K, Di Scala C, Di Pasquale E, et al. The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1. Neurotoxicology 2010;31:475–84.
   PubMed Web of Science ®Google Scholar
• Fioramonti J, Dupuy C, Dupuy J, Bueno L. The mycotoxin deoxynivalenol delays gastric emptying trough serotonin-3 receptors in rodents. J Pharmacol 1993;266:255–60.
   Google Scholar
• Prelusky DB. The effect of low-level deoxynivalenol on neurotransmitter levels measured in pig cerebral spinal fluid. J Environ Sci Health B 1993;28:731–61.
   PubMed Web of Science ®Google Scholar
• Girish CK, MacDonald EJ, Scheinin M, Smith TK. Effects of feedborne Fusarium mycotoxins on brain regional neurochemistry of Turkeys. Poult Sci 2008;87:1295–302.
   PubMed Web of Science ®Google Scholar
• De Sarro GB, Donato A, Bagetta G, Pujia A, Nisticò G. Behavioural and electrocortical spectrum power changes after intraventricular injection of patulin in rats. Arch Toxicol 1984;7:420–4.
   Google Scholar
• Gardiner DM, Waring P, Howlett BJ. The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis. Microbiology 2005;151:1021–32.
   PubMed Web of Science ®Google Scholar
• Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun 2005;73:635–7.
   PubMed Web of Science ®Google Scholar
• Scharf DH, Remme N, Heinekamp T, Hortschansky P, Brakhage AE, Hertweck C. Transannular disulfide formation in gliotoxin biosynthesis and its role in self-resistance of the human pathogen Aspergillus fumigatus. J Am Chem Soc 2010;132:10136–41.
   PubMed Web of Science ®Google Scholar
• Pennesi CM, Klein LC. Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: based on parental report. Nutr Neurosci 2012;15:85–91.
   PubMed Web of Science ®Google Scholar
• Cass H, Gringras P, March J, McKendrick I, O'Hare AE, Owen L, et al. Absence of urinary opioid peptides in children with autism. Arch Dis Child 2008;93:745–50.
   PubMed Web of Science ®Google Scholar
• Barcia G, Posar A, Santucci M, Parmeggiani A. Autism and coeliac disease. J Autism Dev Disord 2008;38:407–8.
   PubMed Web of Science ®Google Scholar
• Genuis SJ, Bouchard TP. Celiac disease presenting as autism. J Child Neurol 2010;25:114–9.
   PubMed Web of Science ®Google Scholar
• Batista IC, Gandolfi L, Nobrega YK, Almeida RC, Almeida RM, et al. Autism spectrum disorder and celiac disease: no evidence for a link. Arq Neuropsiquiatr 2012;70:28–33.
   PubMed Web of Science ®Google Scholar
• Griffin M, Casadio R, Bergamini CM. Transglutaminases: nature's biological glues. Biochem J 2002;368:377–96.
   PubMed Web of Science ®Google Scholar
• Facchiano F, Deloye F, Doussau F, Innamorati G, Ashton AC, Dolly JO, et al. Transglutaminase participates in the blockade of neurotransmitter release by tetanus toxin: evidence for a novel biological function. Amino Acids 2010;39:257–69.
   PubMed Web of Science ®Google Scholar
• Rosenspire A, Yoo W, Menard S, Torres AR. Autism spectrum disorders are associated with an elevated autoantibody response to tissue transglutaminase-2. Autism Res 2011;4:242–9.
   PubMed Web of Science ®Google Scholar
• Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011;25:40–5.
   PubMed Web of Science ®Google Scholar
• Boulanger LM. Immune proteins in brain development and synaptic plasticity. Neuron 2009;64:93–109.
   PubMed Web of Science ®Google Scholar
• Coutellier L, Beraki S, Ardestani PM, Saw NL, Shamloo M. Npas4: a neuronal transcription factor with a key role in social and cognitive functions relevant to developmental disorders. PLoS ONE 2012;7:e46604.
   PubMed Web of Science ®Google Scholar
• Lintas C, Sacco R, Persico AM. Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol Dis 2012;45:57–68.
   PubMed Web of Science ®Google Scholar
• Ziats MN, Rennert OM. Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways. PLoS ONE 2011;6:e24691.
   PubMed Web of Science ®Google Scholar
• Sharif O, Bolshakov NV, Raines S, Newham P, Perkins ND. Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunol 2007;8:1.
   PubMed Web of Science ®Google Scholar
• Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999;18:6853–66.
   PubMed Web of Science ®Google Scholar
• Perkins ND. NF-κB: Tumor promoter or suppressor? Trends Cell Biol 2004;14:64–9.
   PubMed Web of Science ®Google Scholar
• Naik US, Gangadharan C, Abbagni K, Nagalla B, Dasari N, Manna SK. A study of nuclear factor-kappaB in childhood autism. PLoS ONE 2011;6:e19488.
   PubMed Web of Science ®Google Scholar
• Young AMH, Campbell E, Lynch S, Suckling J, Powis SJ. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation. Front Psychiatry 2011;2:27.
   PubMedGoogle Scholar
• Gopee NV, He Q, Sharma RP. Fumosin B1-induced apoptosis is associated with delayed inhibition of protein kinase C, nuclear factor-κB and tumor necrosis factor α in LLC-PK1 cells. Chem Biol Interact 2003;146:131–45.
   PubMed Web of Science ®Google Scholar
• Cavin C, Delatour T, Marin-Kuan M, Fenaille F, Holzhauser D, Guignard G, et al. Ochratoxin A-mediated DNA and protein damage: Roles of nitrosative and oxidative stresses. Toxicol Sci 2009;110:84–94.
   PubMed Web of Science ®Google Scholar
• Wong SS, Zhou HR, Pestka JJ. Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-kappaB, and NF-IL6 in raw 264.7 macrophage cells. J Toxicol Environ Health A 2002;65:1161–80.
   PubMed Web of Science ®Google Scholar
• Pestka JJ. Mechanisms of deoxynivalenol-induced gene expression and apoptosis. Food Addit Contam A Chem Anal Control Expo Risk Assess 2008;25:1128–40.
   Web of Science ®Google Scholar
• Pestka JJ. Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae. Toxin 2010;2:1300–17.
   Web of Science ®Google Scholar
• Moon Y, Pestka JJ. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophage mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicol Sci 2002;69:373–82.
   PubMed Web of Science ®Google Scholar
• Sajdel-Sulkowska EM, Xu M, Koibuchi N. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum 2009;8:366–72.
   PubMed Web of Science ®Google Scholar
• Ziats NM, Rennert OM. Sex-biased gene expression in the developing brain: implications for autism spectrum disorders. Mol Autism 2013;4:10.
   PubMed Web of Science ®Google Scholar
• Ueta E, Kodama M, Sumino Y, Kurome M, Ohta K, Katagiru R, et al. Gender-dependent differences in the incidence of ochratoxin A-induced neural tube defects in the Pdn/Pdn mouse. Congenit Anom (Kyoto) 2010;50:29–39.
   PubMed Web of Science ®Google Scholar
• Barrionuevo F, Scherer G. SOX E genes: SOX9 and SOX8 in mammalian testis development. Int J Biochem Cell Biol 2010;42:433–6.
   PubMed Web of Science ®Google Scholar
• Ghahramani Seno MM, Hu P, Gwadry FG, Pinto D, Marshall CR, et al. Gene and miRNA expression profiles in autism spectrum disorders. Brain Res 2011;1380:85–97.
   PubMed Web of Science ®Google Scholar
• Tryphonas H, Bondy G, Miller JD, Lacroix F, Hodgen M, Mcguire P, et al. Effects of fumonisin B1 on the immune system of Sprague-Dawley rats following a 14-day oral (gavage) exposure. Fundam Appl Toxicol 1997;39:53–9.
   PubMedGoogle Scholar
• Marin DE, Taranu I, Pascale F, Lionide A, Burlacu R, Bailly JD, et al. Sex-related differences in the immune response of weanling piglets exposed to low doses of fumonisin extract. Br J Nutr 2006;95:1185–92.
   PubMed Web of Science ®Google Scholar
• Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the brain: implications for explaining autism. Science 2005;310:819–23.
   PubMed Web of Science ®Google Scholar
• Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C, et al. Genes related to sex steroids, neural growth, and social–emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res 2009;2:157–77.
   PubMed Web of Science ®Google Scholar
• Sarachana T, Xu M, Wu RC, Hu VW. Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. PLoS ONE 2011;6:e17116.
   PubMed Web of Science ®Google Scholar
• Fink-Gremmels J, Malekinejad H. Clinical effects and biochemical mechanisms associated with exposure to the mycoestrogen zearalenone. Animal Feed Sci Technol 2007;137:326–41.
   Web of Science ®Google Scholar
• Zeiner AR, Kegg PS, Blackburn M, Stratton R. Gender differences in peak acetaldehyde concentration after an acute dose of ethanol. Neurobehav Toxicol Teratol 1983;5:201–4.
   PubMedGoogle Scholar
• Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. Microbiota is essential for social development in the mouse. Mol Psychiatry 2013;65:1–2.
   Google Scholar
• Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008;8:737–44.
   PubMed Web of Science ®Google Scholar
• McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz) 2011;59:203–13.
   PubMed Web of Science ®Google Scholar
• Loyd DR, Murphy AZ. Androgen and estrogen (alpha) receptor localization on periaqueductal gray neurons projecting to the rostral ventromedial medulla in the male and female rat. J Chem Neuroanat 2008;36:216–26.
   PubMed Web of Science ®Google Scholar
• Loyd DR, Morgan MM, Murphy AZ. Morphine preferentially activates the periaqueductal gray–rostral ventromedial medullary pathway in the male rat: a potential mechanism for sex differences in antinociception. Neuroscience 2007;147:456–68.
   PubMed Web of Science ®Google Scholar
• Loyd DR, Morgan MM, Murphy AZ. Sexually dimorphic activation of the periaqueductal gray–rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat. Eur J Neurosci 2008;27:1517–24.
   PubMed Web of Science ®Google Scholar
• Loyd DR, Wang X, Murphy AZ. Sex differences in μ-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia. J Neurosci 2008;28:14007–17.
   PubMed Web of Science ®Google Scholar